UVAX BIO
Live / Allowed — First extension granted (statement of use) (as of 13 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Sept 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98199205
- Mark type
- Word mark
- Filed
- 27 Sept 2023
- Published for opposition
- 18 Nov 2025
- Attorney of record
- Jeffrey B. Safran, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: Vaccines
Owner
- Uvax Bio LLC, Dover, DE, US
- Uvax Bio LLC, Dover, DE, US
Prosecution history
- 14 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Jul 2026 — SOU EXTENSION 1 GRANTED
- 13 Jul 2026 — SOU EXTENSION 1 FILED
- 13 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Nov 2025 — PUBLISHED FOR OPPOSITION
- 12 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 06 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 06 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 25 Jul 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jul 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jul 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED